16
Publications
888
Citations
13
H-Index
2017
Active since
Ruocong Zhao is an author at Guangzhou Institutes of Biomedicine and Health specializing in immunology, immunotherapy, and medicine.
Top concepts
MedicineImmunologyCell BiologyImmunotherapyAutoimmunityCell SignalingT Cell ImmunityTumor MicroenvironmentInflammationTumor Immunity
Publications per year
2017–2022
16
16
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
Jiang Lv, Ruocong Zhao, Di Wu et al. · Journal of Hematology & Oncology · 2019 · 137 citations · Full text
PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells
Xinru Wei, Yunxin Lai, Jin Li et al. · OncoImmunology · 2017 · 132 citations · Full text
Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells
Yunxin Lai, Jianyu Weng, Xuefeng Wei et al. · Leukemia · 2017 · 103 citations
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
Le Qin, Ruocong Zhao, Dongmei Chen et al. · Biomarker Research · 2020 · 65 citations · Full text
Rows per page
1–5 of 16